Vaccines Against Trypanosomatids
- Authors: Rafael Freitas e Silva, Maria Carolina Accioly Brelaz de Castro, Suenia da Cunha Goncalves de Albuquerque, Diego Cavalcanti Tavares, Milena de Paiva Cavalcanti5, Valeria Alves Pereira6
-
View Affiliations Hide Affiliations5 Aggeu Magalhaes Research Center, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil. 6 Aggeu Magalhaes Research Center, Oswaldo Cruz Foundation, Recife, Pernambuco, Brazil.
- Source: Tropical Diseases: An Overview of Major Diseases Occurring in the Americas , pp 88-113
- Publication Date: December 2017
- Language: English
Preview this chapter:
Vaccines Against Trypanosomatids, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781681085876/chapter-3-1.gif
The control of diseases caused by trypanosomatids, such as those caused by Leishmania spp. and Trypanosoma cruzi, is focused on the use of drugs to treat infected patients, which are limited by their high cost, high toxicity and safety concerns, in the absence of an effective and safe vaccine for use in humans. Therefore, new strategies for vaccines have emerged in the last years and better perspectives for the future are expected. In this context, the aim of this chapter is to discuss the past, present and future of vaccines against Leishmania spp. and Trypanosoma cruzi. In addition, we indicate important aspects for the development of anti-trypanosomatids vaccines.
Hardbound ISBN:
9781681085883
Ebook ISBN:
9781681085876
-
From This Site
/content/books/9781681085876.chapter-3dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
/content/books/9781681085876.chapter-3
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9781681085876
Book
false
en
